SLC25A16 Antikörper
Kurzübersicht für SLC25A16 Antikörper (ABIN207568)
Target
Alle SLC25A16 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Synthetic peptide corresponding to middle residues of human GDC (Grave's disease carrier protein)
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human SLC25A16.
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- SLC25A16 (Solute Carrier Family 25 (Mitochondrial Carrier, Graves Disease Autoantigen), Member 16 (SLC25A16))
-
Andere Bezeichnung
- SLC25A16 / GDA / Graves
-
Hintergrund
-
Name/Gene ID: SLC25A16
Subfamily: Mitochondrial carrier
Family: Transporter
Synonyms: SLC25A16, D10S105E, Graves disease autoantigen, Graves', HML7, HGT.1, Graves, ML7, GDC, Graves disease carrier protein, Graves' disease autoantigen -
Gen-ID
- 8034
-
UniProt
- P16260
Target
-